Evidence map›Paper›PMID 28468970›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Concomitant Disruption of

Vaidehi R Chowdhary, Ashton Krogman, Ashenafi Y Tilahun, Mariam P Alexander, Chella S David, Govindarajan Rajagopalan

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Vaidehi R ChowdharyDivision of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN 55905.
Ashton KrogmanDepartment of Immunology, Mayo Clinic, Rochester, MN 55905; and.
Ashenafi Y TilahunDepartment of Immunology, Mayo Clinic, Rochester, MN 55905; and.
Mariam P AlexanderDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.
Chella S DavidDepartment of Immunology, Mayo Clinic, Rochester, MN 55905; and.
Govindarajan RajagopalanDepartment of Immunology, Mayo Clinic, Rochester, MN 55905; and rajagopalan.govindarajan@mayo.edu.
Mayo Clinic in Arizona · US

Funding

HLA class II transgenic mouse models for S. aureus infections and superantigensR01AI068741 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI RAJAGOPALAN, GOVINDARAJAN · 2007 to 2016
$3.1M
NIAID NIH HHS R01 AI068741
6 · The paper itself

Abstract

Mature peripheral double negative T (DNT) cells expressing αβ TCR but lacking CD4/CD8 coreceptors play protective as well as pathogenic roles. To better understand their development and functioning in vivo, we concomitantly inactivated

Indexed as

AnimalsCD4 AntigensCD8 AntigensEnterotoxinsHistocompatibility Antigens Class IIHLA-DQ AntigensHLA-DR3 AntigenMiceMice, KnockoutMice, TransgenicReceptors, Antigen, T-Cell, alpha-betaSpleenSuperantigensThymus GlandT-Lymphocyte SubsetsCD4 AntigensCD8 Antigensenterotoxin B, staphylococcalEnterotoxinsHistocompatibility Antigens Class IIHLA-DQ8 antigenHLA-DQ AntigensHLA-DR3 AntigenReceptors, Antigen, T-Cell, alpha-betaSuperantigens

Identifiers

PMID28468970
PMCPMC5471834
OpenAlexW2612635863

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.